Immune Response News and Research

RSS

Plant virus-derived treatment shows promise against metastatic cancers

An experimental treatment made from a plant virus is effective at protecting against a broad range of metastatic cancers in mice, shows a new study from the University of California San Diego.

13 May 2024

Measles vaccine more likely to be completely ineffective in children born by C-section

A study by the University of Cambridge, UK, and Fudan University, China, has found that a single dose of the measles jab is up to 2.6 times more likely to be completely ineffective in children born by C-section, compared to those born naturally.

13 May 2024

Study spotlights differences based on race and gender in melanoma diagnosis, outcomes

Melanoma, an aggressive form of skin cancer that accounts for 75% of all skin-cancer-related deaths, is often detected later in people with darker skin complexions -; and the consequences can be devastating, a Mayo Clinic study reveals.

10 May 2024

Breakthrough research offers promise for developing new immune therapies for cancer

Scientists from Trinity College Dublin have made an important breakthrough that offers promise for developing new immune therapies for cancer.

9 May 2024

Combination immunotherapy treatment enhances immune response for people with malignant gliomas

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have pinpointed a combination immunotherapy treatment that enhances the immune response for people with malignant gliomas, an aggressive type of brain tumor that is fast growing and difficult to treat.

9 May 2024

Study examines association between neighborhood disadvantage and DNA methylation in brain tissue

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 8, entitled, "The association between neighborhood deprivation and DNA methylation in an autopsy cohort."

9 May 2024

Enhancing the ability of natural killer cells to combat hematologic malignancies

A new study reveals a groundbreaking approach to immunotherapy, demonstrating that blocking the interaction between the CD300A receptor and phosphatidylserine (PS) significantly enhances the ability of human natural killer (NK) cells to lyse hematologic malignancies (HMs).

9 May 2024

Researchers discover potential new treatment for alopecia areata

Researchers at MIT, Brigham and Women's Hospital, and Harvard Medical School have developed a potential new treatment for alopecia areata, an autoimmune disorder that causes hair loss and affects people of all ages, including children.

9 May 2024

First-in-class drug could prevent sepsis-related organ failure and death

A new drug could prevent sepsis-related organ failure and death by restoring the health of a patient's blood vessels.

8 May 2024

Study unveils crucial insights into how COVID-19 vaccines mitigate severe illness

A landmark study by scientists at the University of Oxford, has unveiled crucial insights into the way that COVID-19 vaccines mitigate severe illness in those who have been vaccinated.

8 May 2024

Tailored vaccine may hold the key to treating eczema in children

New research from a multi-disciplinary team at Trinity College Dublin suggests a "tailored vaccine" might hold the key to treating bacteria-driven flares of eczema in children.

8 May 2024

New Quartet nanocage vaccine shows promise against coronavirus variants

Researchers have developed a novel vaccination approach using Quartet nanocages that display receptor-binding domains (RBDs) from different sarbecoviruses, showing enhanced immune responses and potential protection against diverse coronavirus strains including SARS-CoV-2 and its variants.

8 May 2024

Wayne State University researcher receives NIH grant to tackle diabetic eye infections

Fu-Shin Yu, Ph.D., professor of ophthalmology, visual and anatomical sciences in the Wayne State University School of Medicine, received an award from the National Eye Institute of the National Institutes of Health for his study aiming to reverse the adverse effects of diabetes on eyesight.

7 May 2024

Immune Response News and Research

Plant virus-derived treatment shows promise against metastatic cancers

Measles vaccine more likely to be completely ineffective in children born by C-section

Study spotlights differences based on race and gender in melanoma diagnosis, outcomes

Breakthrough research offers promise for developing new immune therapies for cancer

Combination immunotherapy treatment enhances immune response for people with malignant gliomas

Study examines association between neighborhood disadvantage and DNA methylation in brain tissue

Enhancing the ability of natural killer cells to combat hematologic malignancies

Researchers discover potential new treatment for alopecia areata

First-in-class drug could prevent sepsis-related organ failure and death

Study unveils crucial insights into how COVID-19 vaccines mitigate severe illness

Tailored vaccine may hold the key to treating eczema in children

New Quartet nanocage vaccine shows promise against coronavirus variants

Wayne State University researcher receives NIH grant to tackle diabetic eye infections

Bacterial fatty acid metabolite identified as key player in immune regulation

Neural circuits revealed as key regulators in body's immune response, study finds

New vaccine technology provides protection against broad range of coronaviruses in mice

Durable lymph-node expansion improves vaccine responses against tumors

New influenza vaccine strategies aim to enhance protection with T-cell responses

High-fat diet accelerates aging-related memory loss in rats

Novel vaccine approach targets AML and other blood cancers

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News